New Delhi, Mar 3 () Drug firm GlaxoSmithKline Pharmaceuticals on Tuesday said it has appointed Sridhar Venkatesh as managing director & vice president of GSK India, effective April 1, 2020.

GSK is to spend over US $1 billion to increase its stakes in its consumer healthcare subsidiaries in India and Nigeria. GSK will increase its share of its publicly-listed Consumer Healthcare ...

India's Intellectual Property Appellate Board (IPAB) has revoked the patent for global pharmaceutical company, GlaxoSmithKline's anti-cancer drug Tykerb. Tykerb (lapatinib) is a dual tyrosine ...

GlaxoSmithKline Pharmaceuticals Ltd. (‘GSK India’) announces completion of its transaction with Novartis Healthcare Pvt. Ltd. ... GSK Pharma's Bengaluru facility to be operational by 2017 The ...

However, after the deal is completed at the end of 2019, by which time HUL will be India’s largest publicly-listed food and refreshments company, GSK plans to sell its stake in HUL in what is ...

New Delhi: GlaxoSmithKline's antibiotic drug Augmentin has risen to the top slot in the Indian pharmaceutical market, pushing the popular anti-diabetes drug Glycomet GP to the second slot.